Literature DB >> 2099192

Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

L A Pukac1, J J Castellot, T C Wright, B L Caleb, M J Karnovsky.   

Abstract

Heparin is a potent inhibitor of vascular smooth muscle cell (VSMC) growth. In this paper we show that heparin suppressed the induction of c-fos and c-myc mRNA in rat and calf VSMC. This effect of heparin is closely associated with its growth-inhibitory activity, as shown by isolating and characterizing a strain of rat VSMC that was resistant to heparin's antiproliferative effect; heparin did not suppress c-fos mRNA induction in these cells. Moreover, neither a nonantiproliferative heparin fragment or other glycosaminoglycans that lack growth-inhibitory activity repressed c-fos or c-myc mRNA levels. The effect of heparin on c-fos mRNA induction was selective for specific mitogens, as heparin inhibited c-fos mRNA induction in phorbol 12-myristate 13-acetate (TPA) stimulated but not epidermal growth factor (EGF) stimulated VSMC. The effect of heparin on gene expression is independent of ongoing protein synthesis, and inhibition of c-fos mRNA is at the transcriptional level. These results suggest that heparin may selectively inhibit a protein kinase C-dependent pathway for protooncogene induction and that this may be one mechanism used by heparin to inhibit cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2099192      PMCID: PMC361524          DOI: 10.1091/mbc.1.5.435

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  46 in total

1.  Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor.

Authors:  M Einat; D Resnitzky; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

2.  Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.

Authors:  W E Benitz; D S Lessler; J D Coulson; M Bernfield
Journal:  J Cell Physiol       Date:  1986-04       Impact factor: 6.384

3.  Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA.

Authors:  M S Kindy; G E Sonenshein
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

5.  Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.

Authors:  K Nishikura; J M Murray
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 6.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

7.  Heparin inhibition of smooth muscle cell proliferation: a cellular site of action.

Authors:  C F Reilly; L M Fritze; R D Rosenberg
Journal:  J Cell Physiol       Date:  1986-10       Impact factor: 6.384

8.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

Authors:  J T Holt; T V Gopal; A D Moulton; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression.

Authors:  K Takehara; E C LeRoy; G R Grotendorst
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

10.  Induction of c-fos and c-myc mRNA by epidermal growth factor or calcium ionophore is cAMP dependent.

Authors:  W Ran; M Dean; R A Levine; C Henkle; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  22 in total

1.  Iron-loaded cardiac myocytes stimulate cardiac myofibroblast DNA synthesis.

Authors:  Ying Liu; Douglas M Templeton
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture.

Authors:  K Miyazawa; S Hamano; A Ujiie
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  The heparin-binding lectin from ovine placenta: purification and identification as histone H4.

Authors:  A L Ambrosio; M M Iglesias; C Wolfenstein-Todel
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

4.  Heparin inhibits phosphorylation and autonomous activity of Ca(2+)/calmodulin-dependent protein kinase II in vascular smooth muscle cells.

Authors:  Ketu Mishra-Gorur; Harold A Singer; John J Castellot
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Heparin inhibits Ca2+/calmodulin-dependent kinase II activation and c-fos induction in mesangial cells.

Authors:  T Miralem; D M Templeton
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes.

Authors:  M Heinzelmann; M Miller; A Platz; L E Gordon; D O Herzig; H C Polk
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

7.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Phorbol 12-myristate 13-acetate-mediated signalling in murine bone marrow cells.

Authors:  D Visnjić; D Batinić; Z Lasić; M Knotek; M Marusić; H Banfić
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans.

Authors:  S A Kilfeather; S Tagoe; A C Perez; K Okona-Mensa; R Matin; C P Page
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Authors:  Somali Chaterji; Kinam Park; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.